
Kewaunee Scientific Corporation
KEQUNASDAQConsumer Cyclical● Active
$36.55
$-0.86(-2.30%)
Market Cap$104766335
P/E Ratio—
52W High$60.89
52W Low$33.7
Kewaunee Scientific Corporation (KEQU) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · KEQU · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-04 | 2024-04 | 2023-04 | 2022-04 | 2021-04 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.20B | $0.22B | $0.17B | $0.15B |
| Cost of Revenue | $0.17B | $0.15B | $0.18B | $0.14B | $0.12B |
| Gross Profit | $0.07B | $0.05B | $0.04B | $0.02B | $0.02B |
| Gross Margin %(computed) | 28.63% | 25.55% | 16.21% | 14.34% | 16.27% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.05B | $0.04B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.05B | $0.03B | $0.03B | $0.03B | $0.03B |
| Operating Income | $0.02B | $0.02B | $0.00B | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | 7.39% | 8.97% | 1.65% | -1.54% | -0.89% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | $0.00B | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | ($0.01B) | $0.00B | $0.00B | $0.00B |
| Net Income | $0.01B | $0.02B | $0.00B | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | 4.74% | 9.20% | 0.62% | -3.55% | -2.45% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.98 | $6.51 | $0.48 | $-2.15 | $-1.31 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| EBITDA Margin %(computed) | 9.46% | 8.86% | 3.72% | 0.54% | 0.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Kewaunee Scientific Corporation data
About Kewaunee Scientific Corporation (KEQU) Income Statement
Kewaunee Scientific Corporation (KEQU) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, KEQU reported revenue of $0.24B, gross profit of $0.07B (gross margin 28.63%), and net income of $0.01B — a net profit margin of 4.74%.
Frequently asked questions
KEQU · 4 questionsKewaunee Scientific Corporation (KEQU) reported revenue of $0.24B for 2025, up 18.0% year-over-year.
KEQU revenueKEQU salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08